What is terazosin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Terazosin?

Terazosin is a selective alpha-1 adrenergic receptor blocking medication used to treat two conditions: high blood pressure (hypertension) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH) in men. 1

Mechanism of Action

Terazosin works by relaxing smooth muscle through selective blockade of alpha-1 adrenergic receptors 1:

  • For hypertension: It relaxes blood vessel walls, allowing blood to pass through more easily and lowering blood pressure
  • For BPH: It relaxes the tightness of muscles in the prostate and at the bladder opening, which increases urine flow rate and decreases urinary symptoms

Chemical Properties

Terazosin hydrochloride is a quinazoline derivative that is structurally similar to prazosin but with important differences 1, 2:

  • Water solubility: 25 times greater than prazosin
  • Half-life: Approximately 12 hours—about 3-4 times longer than prazosin 2, 3
  • This longer half-life allows once-daily dosing, which improves patient compliance

Clinical Uses

For Hypertension

Terazosin effectively lowers blood pressure in patients with mild-to-moderate essential hypertension 1, 2. It can be used alone or in combination with diuretics and other antihypertensive agents.

For BPH

Terazosin is NOT a first-line alpha blocker for BPH treatment 4. Current guidelines recommend uroselective alpha blockers (tamsulosin, alfuzosin, or silodosin) as preferred agents because older, non-uroselective alpha blockers like terazosin and doxazosin have higher rates of orthostatic hypotension and dizziness 4.

However, if patients are already well-controlled on terazosin without side effects, there is no reason to discontinue it and switch to uroselective agents 4.

Dosing and Administration

  • Initial dose: 1 mg at bedtime 1
  • Titration: Can be increased gradually based on response
  • Typical maintenance: 2-10 mg once daily
  • Onset of symptom relief for BPH: 2-4 weeks 1

Important Clinical Considerations

Advantages

  • Once-daily dosing improves compliance 2, 3
  • Favorable lipid profile effects: Unlike diuretics and beta-blockers, terazosin may reduce total cholesterol and LDL cholesterol while potentially increasing HDL cholesterol 3

Key Adverse Effects

The most significant limitation is cardiovascular side effects 4:

  • Orthostatic hypotension (postural blood pressure drops)
  • Dizziness
  • Asthenia (weakness)
  • Peripheral edema

These side effects occur more frequently than with uroselective alpha blockers, which is why terazosin is no longer preferred for BPH 4.

Critical Safety Warning

Patients should be counseled about first-dose syncope risk—take the first dose at bedtime and rise slowly from sitting or lying positions to minimize orthostatic hypotension 1.

Current Clinical Position

While terazosin remains FDA-approved and effective for both hypertension and BPH, modern practice has largely moved away from it as a first-line BPH treatment in favor of uroselective alpha blockers with better side effect profiles 4. For hypertension, other drug classes are typically preferred as first-line agents in contemporary guidelines.

The main scenario for continuing terazosin is in patients already stable on the medication without problematic side effects 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.